Posted on 6/20/19
Dana-Farber Announces $20 Million Gift from the Saverin Family for Metastatic Breast Cancer Research
BOSTON--(BUSINESS WIRE)--A $20 million gift announced today from the Saverin Family will establish the Saverin Breast Cancer Research Fund at Dana-Farber Cancer Institute under the direction . . .
Posted on 6/20/19
Axial Biotherapeutics Announces $10M Investment from Taiho Ventures
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders
Posted on 6/20/19
Biogen, Inc. (BIIB) 2019 Annual Meeting of Stockholders Conference (Transcript)
Biogen, Inc. (NASDAQ:BIIB) 2019 Annual Meeting of Stockholders Conference Call June 19, 2019 9:00 AM ETCompany ParticipantsStelios Papadopoulos - ChairmanMichel Vounatsos - CEOSusan Alexander - EVP, . . .
Posted on 6/20/19
Morphic Holding Files Proposed Terms For IPO
SummaryMorphic intends to raise $75 million from the sale of its common stock in an IPO.The firm is an ultra-early-stage company advancing a pipeline of treatments . . .
Posted on 6/20/19
Genocea Prices $36,750,000 Public Offering of Common Stock
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced the pricing of its . . .
Posted on 6/19/19
Scholar Rock Prices Public Offering of Common Stock
CAMBRIDGE, Mass., June 19, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in . . .
Posted on 6/19/19
Eloxx Pharmaceuticals Proposes Public Offering of Common Stock
WALTHAM, Mass, June 19, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) today announced that it intends to offer and sell shares of its common . . .
Posted on 6/19/19
Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel
BASEL, Switzerland & BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and Lonza (SWX: LONN), an integrated healthcare solutions provider, today . . .
Posted on 6/19/19
Sesen Bio Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the pricing . . .
Posted on 6/19/19
Brigham Women’s Physician Organization Partners with IKS Health
BOSTON--(BUSINESS WIRE)--Brigham Women’s Physicians Organization (BWPO), a leading global healthcare provider, today announced its new partnership with IKS Health, a premier healthcare solutions organization, to address . . .
Posted on 6/19/19
Comet Therapeutics Raises $28.5 Million Series A Financing
Comet Therapeutics, a company built around the unique ability to re-engineer Coenzyme A (CoA)-related metabolism, has raised $28.5 million in Series A funding
Posted on 6/19/19
Pfizer-Array Deal: Growth And Pipeline Addition
SummaryPfizer acquires Array in a +$11 billion deal.While very large in dollar terms, the deal is just a bolt-on deal for Pfizer, adding some growth potential . . .
Posted on 6/19/19
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
This week got off to a rousing start for the biopharmaceutical world with Pfizer's (NYSE:PFE)announcement that it's acquiring Array BioPharma (NASDAQ:ARRY) for $11.4 billion. Anytime there's . . .
Posted on 6/19/19
Scholar Rock Proposes Public Offering of Common Stock
CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in . . .
Posted on 6/19/19
Genocea Proposes Public Offering of Common Stock
CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has commenced . . .
Posted on 6/19/19
Stoke Therapeutics Prices IPO
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc., a biotechnology company that is pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein . . .
Posted on 6/19/19
Sesen Bio Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that it . . .
Posted on 6/18/19
Boston Children's Hospital Ranked #1 In The Nation By U.S. News & World Report For Sixth Year In A Row
Boston Children's Hospital is the number one pediatric hospital in the nation for the sixth year in a row according to U.S. News & World Report's . . .
Posted on 6/18/19
Regulatory Approvals Obtained for the Sale of Brooks' Semiconductor Cryogenics Business to Atlas Copco
Brooks Automation, Inc. (Nasdaq: BRKS) announced today that all required regulatory approvals, including the approval of the Committee on Foreign Investment in the United States (CFIUS), . . .
Posted on 6/18/19
Ampersand Completes Growth Equity Investment In N2 Biomedical
N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, announced today the majority recapitalization of the company by Ampersand . . .
Posted on 6/18/19
Zoll Medical Corporation Acquires TherOx
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has acquired TherOx, Inc., of . . .
Posted on 6/18/19
CarePort Partners with Audacious Inquiry
BOSTON--(BUSINESS WIRE)--CarePort Health, a pioneer in post-acute outcomes management, today announced its partnership with Baltimore-based Audacious Inquiry (Ai), an industry-shaping health information technology and policy company . . .
Posted on 6/18/19
Biohaven Announces Proposed Public Offering Of Common Shares
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical?stage biopharmaceutical company with a portfolio of innovative, late?stage product candidates targeting neurological diseases, including rare disorders, today . . .
Posted on 6/18/19
iCAD Closes Public Offering of Common Stock
NASHUA, N.H., June 17, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today . . .
Posted on 6/17/19
Exceptional Healthcare Innovators Honored by American Well for Digital Care Excellence
American Well, a leading U.S. telehealth company, today announced the recipients of its annual Client Awards. The awards are given to organizations that have made exceptional . . .

